New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Join Princeton Precision Health Seminar Series on 3/21 in Princeton
- Exercise May Lower Your Dementia Risk—Here’s How It Works.
- How New Therapies Are Revolutionizing the Treatment of Juvenile Idiopathic Arthritis.
- NJIT’s Grace Hopper AI Research Institute Launches with $1 Million in Research Proposals.
- Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs.
Categories
- Community (2,169)
- Covid (982)
- CTO Events (6)
- News (2,770)
- Pilots (21)